Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)

Rob Riemsma, Carol A. Forbes, Mayur M. Amonkar, Konstantinos Lykopoulos, Jose R. Diaz, Jos Kleijnen, Daniel W. Rea

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1263-1279
JournalCurrent Medical Research and Opinion
Volume28
Issue number8
DOIs
Publication statusPublished - Aug 2012

Keywords

  • Advanced or metastatic breast cancer
  • Aromatase inhibitor
  • First line treatment
  • HR
  • HER2+
  • Lapatinib

Cite this

@article{e6a4e640e4eb4865aaeefb91b1a7ff8e,
title = "Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)",
keywords = "Advanced or metastatic breast cancer, Aromatase inhibitor, First line treatment, HR, HER2+, Lapatinib",
author = "Rob Riemsma and Forbes, {Carol A.} and Amonkar, {Mayur M.} and Konstantinos Lykopoulos and Diaz, {Jose R.} and Jos Kleijnen and Rea, {Daniel W.}",
year = "2012",
month = "8",
doi = "10.1185/03007995.2012.707643",
language = "English",
volume = "28",
pages = "1263--1279",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "TAYLOR & FRANCIS LTD",
number = "8",

}

Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC). / Riemsma, Rob; Forbes, Carol A.; Amonkar, Mayur M.; Lykopoulos, Konstantinos; Diaz, Jose R.; Kleijnen, Jos; Rea, Daniel W.

In: Current Medical Research and Opinion, Vol. 28, No. 8, 08.2012, p. 1263-1279.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)

AU - Riemsma, Rob

AU - Forbes, Carol A.

AU - Amonkar, Mayur M.

AU - Lykopoulos, Konstantinos

AU - Diaz, Jose R.

AU - Kleijnen, Jos

AU - Rea, Daniel W.

PY - 2012/8

Y1 - 2012/8

KW - Advanced or metastatic breast cancer

KW - Aromatase inhibitor

KW - First line treatment

KW - HR

KW - HER2+

KW - Lapatinib

U2 - 10.1185/03007995.2012.707643

DO - 10.1185/03007995.2012.707643

M3 - Article

VL - 28

SP - 1263

EP - 1279

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 8

ER -